It’s been 10 years since Jenny and Karl Herz started in business. Over the past 10 years they’ve launched Biointelect and Biocelect businesses to help secure approval and distribution for new medicines into Australia.
Biointelect is a strategic planning and commercialisation firm for the biopharmaceutical and medical device sector including commercial, government and not-for-profit organisations.
Biointelect helps its clients develop and drive strategy, identify and evaluate new business opportunities and engage the right partners. The strategy consulting involves therapeutic development from start up through to post launch, with an Australian and a Global perspective.
Biointelect’s mission is to bring science to market.
Biocelect works with local and overseas partners to bring critical pharmaceutical products and medical technology solutions to the Australian market.
In addition to our travel range, infectious disease portfolio and novel medical diagnostics, Biocelect is the sponsor of the Novavax COVID-19 Vaccine, NVX-CoV2373 for Australia and New Zealand.
Biocelect’s mission is to build pathways to patients.
In this Australian Health Journal interview, Jenny and Karl talk about the journey the husband and wife team took to get the Novavax COVID-19 vaccine (Nuvaxovid) approved and distributed in Australia. The journey didn’t just include talented and diverse skilled staff but also their children working in both organisations.
You Might also like
-
Priming Australia for social prescribing
Social prescribing provides support in various areas of people’s lives, leading to increased confidence, improved navigation of systems, and enhanced friendships and trust in healthcare, while communities should be designed in an age-friendly way to prevent isolation.
In Part 1 of the Models of Care on Social Prescribing, Australian Health Journal spoke to 4 people advocating for social prescribing in Australia
-
Dr Anjali Jaiprakash, Robobiologist from Queensland University of Technology
Dr Anjali Jaiprakash is a robobiologist working at the intersection of medicine, engineering and design, with a transdisciplinary approach to develop medical devices that translate robotic vision into affordable systems that can be used to improve healthcare outcomes. Anjali has experience in the fields of medical robotics, medical device, orthopaedics, trauma, bone and cartilage biology. She spoke with Anne Dao following her talk “The Robot Doctor Will See you Now” at Australian Healthcare Week 2019.
Post Views:
932 -
Scott Willis, talks Physiotherapy
Health Executive Leadership Insights (HELI)
Scott Willis, the National President of the Australian Physiotherapy Association talks Physiotherapy